FDA Inspection 1195721 — Seattle Reproductive Medicine, PLLC
The FDA completed an inspection of Seattle Reproductive Medicine, PLLC on January 25, 2023 in Kirkland, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 25, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Kirkland, WA (United States)